| Term 
 
        | Symptoms of Parkinson's Disease |  | Definition 
 
        | 1. Rigidity 2. bradykinesia
 3. resting tremor
 4. postural instability
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Lose dopamine containing neurons w. cell bodies in substantia nigra to striatum -Dark neurons contain high amt melanin
 -70-80% lost before see symptoms
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Aging = gradual loss of nigrostriatal dopamine neurons -Small # genetically linked (eg. mutated a-synuclein)
 -Some toxins such as MPTP selectively kills these neurons
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dopamine precursor converted by DD (Dopa Decarboxylase) enzyme
 -Given w. carbidopa to allow more to enter CNS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Tx lasts 5-10 yrs ON/OFF phenomenon - may be due to diet and competition w/ other amino acids
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Extrapyramidal abnormalities- dyskinesia, nausea, -psych symptoms at high doses
 -postural hypotension
 -Some think may inc. loss of dopaminergic neurons
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | COMT Inhibitor -inhibits conversion of L-Dopa to 3-0 methyldopa in periphery = inc. 1/2 life in PERIPHERY
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Diarrhea -Inc. sensitivity to L-Dopa
 -Hepatotoxicity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Direct acting DA agonist (D1/D2) -Acts on receptors in striatum pathway
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | D2 agonist D3 agonist
 -act directly on DA receptors
 |  | 
        |  | 
        
        | Term 
 
        | Tx Use of Ropinirole & Pramipexole |  | Definition 
 
        | Often combined w. L-DOPA lower doses of each required
 -less side effects than bromocriptine
 |  | 
        |  | 
        
        | Term 
 
        | SEs of Ropinirole & Pramipexole |  | Definition 
 
        | Nausea Dyskinesia
 Confusion
 Hallucinations
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Muscarinic antagonist DA inhibits Ach (which -> GABA release)
 More DA in Striatum
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -Anti-parasympathetic: xerostomia, dec. sweating, inc. HR, urinary retention, dec. short term memory
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Antiviral Inc. DA release
 Unknown mechanism
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Half as efficacious as L-DOPA |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Mild: restlessness
 depression
 hypotension
 |  | 
        |  | 
        
        | Term 
 
        | Contraindication of Amantadine |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAO-B blocker MAO-B metabolizes Dopamine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Low effectiveness Claim neuroprotection
 |  | 
        |  | 
        
        | Term 
 
        | Contraindications of Selegiline |  | Definition 
 
        | NOT w. meperidine or TCA's bc = Hyperthermic of HTN |  | 
        |  |